ArticleBlood cancer journal2011

Signaling changes in the stem cell factor-AKT-S6 pathway in diagnostic AML samples are associated with disease relapse.

S M Kornblau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.